EFFICACY AND SAFETY OF PERCUTANEOUS SCLEROTHERAPY IN THE MANAGEMENT OF HYDATID CYSTS

Abstract

Background: Percutaneous sclerotherapy of hydatid cysts offers a less invasive management of hydatid cysts. The procedure has been documented to yield significant cyst volume reduction of 76%-100%, with up to 100% symptom relief. It is particularly advantageous due to its shorter hospital stay and fewer complications compared to surgery. Long-term follow-up data show that the recurrence rates of percutaneous sclerotherapy are comparable to surgery, but with a safer profile, making it an effective treatment option. Factors like cyst size and location influence treatment success, with smaller cysts responding better.
Complications are generally rare, with major adverse events seldom reported.
Objective: To review the efficacy and safety of percutaneous sclerotherapy as an essential treatment modality for hydatid cysts.
Sources: The search strategy involved systematically searching databases such as PubMed, Scopus, and the Cochrane Library. Studies published from 2015 onwards were included, focusing on those addressing percutaneous sclerotherapy for hydatid cysts.
Content: The review provides a comprehensive understanding of the efficacy, safety, and potential complications of percutaneous sclerotherapy of hydatid cysts. This review also highlights the growing role of percutaneous sclerotherapy in hydatid cyst disease management.
Implications: To enhance the integration of percutaneous sclerotherapy of hydatid cysts into clinical practice to complement existing treatment strategies, offering a reliable alternative for managing hydatid cysts.